Principia Biopharma Inc. - FORM S-1 - EX-23.1 - August 17, 2018

Attached files

file filename
EX-10.1 - EX-10.1 - Principia Biopharma Inc.d575899dex101.htm
EX-3.1 - EX-3.1 - Principia Biopharma Inc.d575899dex31.htm
EX-3.3 - EX-3.3 - Principia Biopharma Inc.d575899dex33.htm
EX-4.1 - EX-4.1 - Principia Biopharma Inc.d575899dex41.htm
EX-4.2 - EX-4.2 - Principia Biopharma Inc.d575899dex42.htm
EX-10.3 - EX-10.3 - Principia Biopharma Inc.d575899dex103.htm
EX-10.12 - EX-10.12 - Principia Biopharma Inc.d575899dex1012.htm
EX-10.13 - EX-10.13 - Principia Biopharma Inc.d575899dex1013.htm
EX-10.14 - EX-10.14 - Principia Biopharma Inc.d575899dex1014.htm
EX-10.16 - EX-10.16 - Principia Biopharma Inc.d575899dex1016.htm
EX-10.18 - EX-10.18 - Principia Biopharma Inc.d575899dex1018.htm
EX-21.1 - EX-21.1 - Principia Biopharma Inc.d575899dex211.htm
EX-10.17 - EX-10.17 - Principia Biopharma Inc.d575899dex1017.htm
EX-10.2 - EX-10.2 - Principia Biopharma Inc.d575899dex102.htm
EX-4.3 - EX-4.3 - Principia Biopharma Inc.d575899dex43.htm
S-1 - S-1 - Principia Biopharma Inc.d575899ds1.htm
EX-10.15 - EX-10.15 - Principia Biopharma Inc.d575899dex1015.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 9, 2018 (except for the third paragraph of Note 13, as to which the date is August 17, 2018) in the Registration Statement (Form S-1) and related Prospectus of Principia Biopharma Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

Redwood City, California

August 17, 2018

Principia Biopharma Inc. Reports